| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f046421e63e2dee2e5725d9a6b49ede |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D81-32 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-661
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
| filingDate |
2010-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5006c6bf0dea6f67153c8c4c981e9369 |
| publicationDate |
2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010323991-A1 |
| titleOfInvention |
Methods and products for treatment of diseases |
| abstract |
The invention provides a method of treating a disease or condition mediated by vascular hyperpermeability in an animal. The method comprises administering an amount of a danazol compound effective to inhibit vascular hyperpermeability and an amount of a second drug effective to treat the disease or condition. The invention further provides a method of inhibiting vascular hyperpermeability when it is a side effect caused by administration of a drug to, or another treatment of, an animal. The method comprises administration of an amount of a danazol compound effective to inhibit the vascular hyperpermeability. The invention also provides a method of modulating the cytoskeleton of endothelial cells in an animal comprising administering an amount of a danazol compound and an amount of a second drug effective to modulate the cytoskeleton. The present invention also relates to pharmaceutical compositions and kits comprising a danazol compound and a second drug. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011171307-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8586568-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014089017-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8227457-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987292-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011171306-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9412161-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10058562-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9351979-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324005-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9233113-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722651-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019090171-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007111972-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9603890-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014043334-A1 |
| priorityDate |
2009-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |